08.20.15
Norway-based CLS Technology AS and Vesta Ingredients, Inc., Indianapolis, IN, have announced that Vesta’s Vitamin K2-MK7 is now approved and recognized by EFSA as a novel food in the E.U. In addition, CLS Technology has been given the exclusive right to distribute it in Europe.
Morten Sundstoe, founder and CEO of CLS Technology, commented, “As one of the founders of NattoPharma, I introduced K2 in the market in 2009. The market for vitamin K2 is still a niche market, because both the quality and price has not been good enough. After years of product development, Vesta has been able to make, what I would say, is the best quality natural K2 at a competitive price.”
He added, “We are very pleased to be VESTA’s representative in Europe, and we see a great potential for our K2 products in Europe now that it is recognized as novel food.”
Morten Sundstoe, founder and CEO of CLS Technology, commented, “As one of the founders of NattoPharma, I introduced K2 in the market in 2009. The market for vitamin K2 is still a niche market, because both the quality and price has not been good enough. After years of product development, Vesta has been able to make, what I would say, is the best quality natural K2 at a competitive price.”
He added, “We are very pleased to be VESTA’s representative in Europe, and we see a great potential for our K2 products in Europe now that it is recognized as novel food.”
